Efficient Inhibition of Ovarian Cancer by Degradable Nanoparticle-Delivered Survivin T34A Gene [Corrigendum]

Abstract

Luo L, Du T, Zhang J, et al. Int J Nanomedicine. 2016;11:501—513. The authors have advised due to an error at the time of figure assembly, Figure 11 on page 510 is incorrect. The correct Figure 11 is shown below. The authors apologize for this error and advise it does not affect the results of the paper. Read the original article

Keywords

• human survivin t34a
• heparin-polyethyleneimine nanoparticles
• gene therapy
• ovarian cancer